Showing results (91-100 of 128) with videos related to

Sort By:
Pageof 13
Antioxidants (Basel, Switzerland)|February 25, 2023
Exploring the Interaction between Fractional Exhaled Nitric Oxide and Biologic Treatment in Severe Asthma: A Systematic ReviewTommaso Pianigiani, Lorenzo Alderighi, Martina Meocci, et al.
Biomarkers in Medicine|July 3, 2020
Krebs von den Lungen-6 as a biomarker for disease severity assessment in interstitial lung disease: a comprehensive reviewMiriana d'Alessandro, Laura Bergantini, Paolo Cameli, et al.
Respiratory Physiology & Neurobiology|September 13, 2020
Galactin-1, 3 and 9: Potential biomarkers in idiopathic pulmonary fibrosis and other interstitial lung diseasesMiriana d'Alessandro, Elda De Vita, Laura Bergantini, et al.
Life (Basel, Switzerland)|October 23, 2021
Strain Echocardiography Is a Promising Tool for the Prognostic Assessment of SarcoidosisPaolo Cameli, Maria Concetta Pastore, Giulia Elena Mandoli, et al.
Lung|May 4, 2021
The Role of Galectins in Chronic Lung Allograft DysfunctionMiriana d'Alessandro, Laura Bergantini, Antonella Fossi, et al.
Internal and Emergency Medicine|November 5, 2020
The role of the combination of echo-HRCT score as a tool to evaluate the presence of pulmonary hypertension in idiopathic pulmonary fibrosisRosa Metella Refini, Gloria Bettini, Esmeralda Kacerja, et al.
Biomedicines|February 24, 2024
Role of BAL and Serum Krebs von den Lungen-6 (KL-6) in Patients with Pulmonary FibrosisPiera Soccio, Giorgia Moriondo, Miriana d'Alessandro, et al.
European Journal of Clinical Investigation|March 24, 2021
Prognostic role of KL-6 in SSc-ILD patients with pleuroparenchymal fibroelastosisMiriana d'Alessandro, Francesca Bellisai, Laura Bergantini, et al.
Lung|July 6, 2022
Cytomegalovirus Infection Is Associated with Development of Chronic Lung Allograft DysfunctionDavid Bennett, Laura Bergantini, Pierluigi Ferrara, et al.
Pageof 13